ACI's Medical Device Patents Conference
Medical Device Patents: Comprehensive and Practical Prosecution and Litigation Strategies for an Evolving IP LandscapeTuesday, February 28 to Wednesday, February 29, 2012The Omni Parker House, Boston, MA
ACI presents a forum dedicated solely to the challenges and opportunities facing medical device patent practitioners in the post-patent reform world. A medical device specific intellectual property conference to provide you with practical and tactical strategies for patent filings and challenges, which are more critical than ever in this time of sweeping change.
On Day One (Tuesday, February 28), Paul Hastings partner Eric Dittmann is a speaker at 3:15 pm to discuss "Resolving the Written Description / Enablement Dichotomy: Practical Claim Drafting Strategies and Litigation Strategies Post-Centocor."• Reaffirming the distinction between written description and enablement set forth in Ariad v. Lilly and comprehending the specific application to medical devices in Centocor Ortho Biotech, Inc. v. Abbott Laboratories - Understanding the heightened tension between the USPTO guidelines regarding § 112 and the Federal Courts mandates• What level of data must be submitted when submitting a new disclosure in order to patent a new use? - Preventing utility / enablement attacks on new uses of established medical devices - Does the Janssen holding regarding new uses translate into the medical device context? - How much info is suffi cient to show one skilled in the art?• Strengthening IP to prevent against design-arounds• Designing around competitors predicates• Exploring the intersection between written description and future invalidity challenges: changes to § 101 patentability post-patent reform• Balancing costs against the scope of patent protection which can realistically be obtained: gaining alignment between file early, file often and successful strategy
For additional information and to register, visit the ACI website